As of 2025-05-15, the Intrinsic Value of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999.SZ) is 49.55 CNY. This 000999.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 42.11 CNY, the upside of China Resources Sanjiu Medical & Pharmaceutical Co Ltd is 17.70%.
The range of the Intrinsic Value is 37.67 - 75.36 CNY
Based on its market price of 42.11 CNY and our intrinsic valuation, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999.SZ) is undervalued by 17.70%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 37.67 - 75.36 | 49.55 | 17.7% |
DCF (Growth 10y) | 48.20 - 93.34 | 62.55 | 48.5% |
DCF (EBITDA 5y) | 48.29 - 75.64 | 58.31 | 38.5% |
DCF (EBITDA 10y) | 54.53 - 86.28 | 66.31 | 57.5% |
Fair Value | 29.80 - 29.80 | 29.80 | -29.24% |
P/E | 40.84 - 51.80 | 46.43 | 10.3% |
EV/EBITDA | 32.28 - 49.49 | 38.92 | -7.6% |
EPV | 21.18 - 27.36 | 24.27 | -42.4% |
DDM - Stable | 20.70 - 57.50 | 39.10 | -7.2% |
DDM - Multi | 42.90 - 85.24 | 56.35 | 33.8% |
Market Cap (mil) | 54,081.87 |
Beta | 1.03 |
Outstanding shares (mil) | 1,284.30 |
Enterprise Value (mil) | 51,585.72 |
Market risk premium | 6.13% |
Cost of Equity | 9.31% |
Cost of Debt | 5.00% |
WACC | 9.09% |